Systemic sclerosis (scleroderma): open trials in Brazil

• NCT05878717

  A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease

  Trial Treatment · Phase 2/3 · GlaxoSmithKline

  GSK Investigational Site, Belo Horizonte · GSK Investigational Site, Curitiba · GSK Investigational Site, Juiz de Fora · GSK Investigational Site, Porto Alegre · GSK Investigational Site, Salvador · GSK Investigational Site, São Paulo

  Registry updated 2026-09-08

• NCT06991114

  AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.

  Trial Treatment · Phase 2 · Artiva Biotherapeutics, Inc.

  Artiva Investigational Site Brasília, Brasília · Artiva Investigational Site Cuiabá, Cuiabá · Artiva Investigational Site Porto Alegre, Porto Alegre · Artiva Investigational Site Rio Grande, Rio Grande · Artiva Investigational Site Sao Paulo, São Paulo

  Registry updated 2026-07-31

• NCT07115745

  A Study of Healthy Donor CD19-targeted Allogeneic CAR T Cells in Participants With Severe, Refractory Autoimmune Diseases

  Trial Treatment · Phase 1 · Juno Therapeutics, Inc., a Bristol-Myers Squibb Company

  Local Institution - 0039, Porto Alegre · Local Institution - 0040, Salvador · Local Institution - 0038, São Paulo

  Registry updated 2026-07-14

All Systemic sclerosis (scleroderma) trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error